Variant report
Variant | nsv827076 |
---|---|
Chromosome Location | chr14:105087128-105097182 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:105056988..105059917-chr14:105095476..105097400,2 | MCF-7 | breast: | |
2 | chr14:105084423..105086474-chr14:105089188..105091844,2 | MCF-7 | breast: | |
3 | chr14:105094448..105097291-chr14:105102750..105105343,2 | K562 | blood: | |
4 | chr14:105093513..105095968-chr14:105096544..105098298,2 | MCF-7 | breast: | |
5 | chr14:105093513..105095968-chr14:105096544..105098298,2 | MCF-7 | breast: | |
6 | chr14:105082698..105084896-chr14:105087171..105089277,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000258986 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373014175 | chr14:105087154-105087155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34537412 | chr14:105087211-105087212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549637222 | chr14:105087219-105087220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142405699 | chr14:105087237-105087238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116870182 | chr14:105087259-105087260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150876996 | chr14:105087283-105087284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537951693 | chr14:105087383-105087384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs71421875 | chr14:105087393-105087394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568770475 | chr14:105087446-105087447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534360174 | chr14:105087453-105087454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139327441 | chr14:105087465-105087466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201518016 | chr14:105087503-105087504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144276209 | chr14:105087531-105087532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556430818 | chr14:105087546-105087547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs199804550 | chr14:105087631-105087632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146554733 | chr14:105087733-105087734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535491904 | chr14:105087794-105087795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372455832 | chr14:105087800-105087801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376416862 | chr14:105087811-105087812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555589455 | chr14:105087812-105087813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111464799 | chr14:105087833-105087834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540960953 | chr14:105087840-105087841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563917935 | chr14:105087852-105087853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141238564 | chr14:105088006-105088007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554074213 | chr14:105088117-105088118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143548818 | chr14:105088120-105088121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563246391 | chr14:105088142-105088143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72713835 | chr14:105088200-105088201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200360107 | chr14:105088230-105088231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111719481 | chr14:105088240-105088241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113078287 | chr14:105088250-105088251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548721936 | chr14:105088266-105088267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562331590 | chr14:105088272-105088273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201139688 | chr14:105088278-105088279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527977259 | chr14:105088283-105088284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145632000 | chr14:105088374-105088375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181256935 | chr14:105088381-105088382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148890047 | chr14:105088398-105088399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550209424 | chr14:105088478-105088479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570054844 | chr14:105088482-105088483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73363311 | chr14:105088545-105088546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555325625 | chr14:105088549-105088550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575818872 | chr14:105088561-105088562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572136258 | chr14:105088567-105088568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10137814 | chr14:105088609-105088610 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs557669691 | chr14:105088621-105088622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577374405 | chr14:105088676-105088677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543253748 | chr14:105088682-105088683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570820288 | chr14:105088711-105088712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186243624 | chr14:105088712-105088713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Breast cancer | 20932292 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:105083200-105088000 | Enhancers | Fetal Brain Male | brain |
2 | chr14:105085600-105091200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr14:105086000-105089000 | Enhancers | Brain Germinal Matrix | brain |
4 | chr14:105086600-105091400 | Weak transcription | Fetal Brain Female | brain |
5 | chr14:105088000-105088400 | Weak transcription | Fetal Brain Male | brain |
6 | chr14:105088400-105089000 | Enhancers | Colon Smooth Muscle | Colon |
7 | chr14:105088400-105089000 | Enhancers | Fetal Brain Male | brain |
8 | chr14:105091200-105091400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr14:105091200-105091400 | Enhancers | Brain Germinal Matrix | brain |
10 | chr14:105091200-105091800 | Enhancers | Fetal Brain Male | brain |
11 | chr14:105091400-105091800 | Enhancers | Fetal Brain Female | brain |
12 | chr14:105091800-105097400 | Weak transcription | Fetal Brain Male | brain |
13 | chr14:105092400-105093000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr14:105096400-105105600 | Weak transcription | Right Atrium | heart |